What is the recommended management of syphilis, including penicillin regimens for each stage and alternatives for penicillin‑allergic patients?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 7, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Syphilis Management

Treatment Regimens by Stage

Benzathine penicillin G is the only proven effective treatment for all stages of syphilis, with specific dosing determined by disease stage. 1

Primary and Secondary Syphilis

  • Benzathine penicillin G 2.4 million units IM as a single dose is the recommended treatment 2, 1, 3
  • This regimen achieves cure rates of 90-95% for primary and secondary syphilis 3
  • All patients diagnosed with syphilis should be tested for HIV if status is unknown 1, 3

Early Latent Syphilis

  • Benzathine penicillin G 2.4 million units IM as a single dose 2, 1, 3
  • Early latent syphilis is defined as infection acquired within the preceding year, documented by seroconversion, fourfold increase in titer, history of symptoms within the past year, or having a sex partner with documented early syphilis 1, 3
  • Cure rate is 85-90% 3

Late Latent Syphilis and Tertiary Syphilis

  • Benzathine penicillin G 7.2 million units total, administered as three doses of 2.4 million units IM at weekly intervals 2, 1, 3
  • This applies to late latent syphilis (acquired >1 year ago), syphilis of unknown duration, and tertiary syphilis (gummatous and cardiovascular disease) 2, 1
  • Cure rate is 80-85% 3
  • If a dose is missed during weekly therapy, an interval of 10-14 days between doses might be acceptable before restarting the sequence; however, missed doses are NOT acceptable for pregnant patients who must repeat the full course 2, 1

Neurosyphilis

  • Aqueous crystalline penicillin G 18-24 million units per day IV (administered as 3-4 million units every 4 hours or continuous infusion) for 10-14 days 2, 1, 3
  • Alternative regimen (if compliance can be ensured): Procaine penicillin 2.4 million units IM once daily PLUS probenecid 500 mg orally four times daily, both for 10-14 days 2, 3
  • Some specialists add benzathine penicillin G 2.4 million units IM weekly for up to 3 weeks after completing neurosyphilis treatment to provide comparable total duration 2, 3
  • CSF examination is indicated for patients with neurologic or ophthalmic signs/symptoms, evidence of active tertiary syphilis, treatment failure, HIV infection with late latent syphilis, or nontreponemal titer ≥1:32 2, 1, 3

Ocular Syphilis

  • Treat according to neurosyphilis recommendations (aqueous crystalline penicillin G 18-24 million units per day IV for 10-14 days) 2, 3
  • Syphilitic uveitis and other ocular manifestations are frequently associated with neurosyphilis 2
  • CSF examination should be performed for all patients with ocular syphilis 2

Alternatives for Penicillin-Allergic Patients

Non-Pregnant Adults

For primary, secondary, and early latent syphilis:

  • Doxycycline 100 mg orally twice daily for 14 days 2, 1
  • Alternative: Tetracycline 500 mg orally four times daily for 14 days 2, 1
  • Ceftriaxone 1 gram IM or IV daily for 10-14 days may be considered based on limited data, though optimal dose and duration are not definitively established 2, 1

For late latent syphilis or syphilis of unknown duration:

  • Doxycycline 100 mg orally twice daily for 28 days 2, 1
  • Alternative: Tetracycline 500 mg orally four times daily for 28 days 2, 1
  • CSF examination must be performed before using non-penicillin therapy to exclude neurosyphilis 1, 3
  • These alternative regimens have limited documentation of effectiveness, especially in HIV-infected persons 2, 3

Critical caveat: Azithromycin should NOT be used in the United States due to widespread macrolide resistance and documented treatment failures 1

Pregnant Patients

All pregnant patients allergic to penicillin MUST undergo desensitization followed by penicillin treatment—no exceptions 2, 1, 3

  • Penicillin is the only therapy with documented efficacy for preventing maternal transmission to the fetus and treating fetal infection 2, 1, 3
  • Tetracycline, doxycycline, erythromycin, azithromycin, and ceftriaxone are inadequate—erythromycin does not reliably cure fetal infection 1
  • Some experts recommend an additional dose of benzathine penicillin G 2.4 million units IM one week after the initial dose for pregnant women with primary, secondary, or early latent syphilis 2, 1, 3
  • Treatment must occur >4 weeks before delivery for optimal outcomes 1, 3

Jarisch-Herxheimer reaction warning: Women treated during the second half of pregnancy are at risk for premature labor and/or fetal distress; they should seek immediate medical attention if they notice contractions or changes in fetal movements 1, 3

Neurosyphilis in Penicillin-Allergic Patients

  • Penicillin remains the only proven effective therapy for neurosyphilis 2, 1
  • Patients must undergo desensitization and be treated with penicillin 2, 1

HIV-Infected Patients

HIV-infected patients should receive the same penicillin regimens as HIV-negative patients for all disease stages 2, 1, 3

  • No additional doses of benzathine penicillin are recommended based on current evidence 1, 3
  • Some experts recommend additional treatments (e.g., three weekly doses as for late syphilis) or CSF examination before therapy for primary/secondary syphilis, though most HIV-infected patients respond appropriately to standard therapy 2

More intensive follow-up is required:

  • Clinical and serological evaluation at 3,6,9,12, and 24 months after therapy 2, 1, 3
  • If nontreponemal titers do not decline fourfold within 3 months for primary/secondary syphilis, CSF examination and possible retreatment are strongly advised 2, 3
  • For late latent syphilis in HIV-infected patients, consider CSF examination before treatment to rule out neurosyphilis 2, 3
  • When CSF is normal, most experts would retreat with benzathine penicillin G 7.2 million units (three weekly doses of 2.4 million units each) 2, 3

Follow-Up and Monitoring

Primary and Secondary Syphilis

  • Quantitative nontreponemal serologic tests (RPR or VDRL) at 6 and 12 months after treatment 2, 1, 3
  • A fourfold decline in titer is expected within 6 months 2, 1, 4
  • Treatment failure is indicated by: failure of titers to decline fourfold within 6 months, fourfold increase in titers at any time, or development of new clinical signs/symptoms 2, 3

Latent Syphilis

  • Quantitative nontreponemal tests at 6,12,18, and 24 months 2, 1, 3
  • For late latent syphilis, a fourfold decline is expected within 12-24 months 2, 3
  • Re-treat if titers increase fourfold, an initially high titer (≥1:32) fails to decline at least fourfold within 12-24 months, or signs/symptoms develop 2, 3

Neurosyphilis

  • If CSF pleocytosis was present initially, repeat CSF examination every 6 months until cell count normalizes 3
  • If cell count has not decreased after 6 months or CSF is not normal after 2 years, consider retreatment 3

Important testing considerations:

  • Sequential RPR tests should use the same method and ideally the same laboratory, as RPR and VDRL titers cannot be directly compared 3
  • Treponemal test antibody titers correlate poorly with disease activity and should not be used to assess treatment response 1
  • Approximately 15% of successfully treated patients may remain "serofast" with persistent low-level titers (<1:8) that do not indicate treatment failure 1, 4

Management of Treatment Failure

When treatment failure occurs:

  • Re-evaluate for HIV infection 2, 3
  • Perform CSF examination to rule out neurosyphilis 2, 3
  • Most specialists recommend re-treating with benzathine penicillin G 2.4 million units IM weekly for 3 weeks, unless CSF indicates neurosyphilis 2, 3
  • If CSF is normal in HIV-infected patients, retreat with benzathine penicillin G 7.2 million units (three weekly doses) 2, 3

Management of Sex Partners

Presumptive treatment is required for exposed partners:

  • Persons exposed within 90 days preceding diagnosis of primary, secondary, or early latent syphilis should be treated presumptively with benzathine penicillin G 2.4 million units IM, even if seronegative 1, 4, 3
  • Time periods for at-risk partners: 3 months plus duration of symptoms for primary syphilis, 6 months plus duration of symptoms for secondary syphilis, and 1 year for early latent syphilis 1, 4
  • Persons exposed >90 days before diagnosis should be treated presumptively if serologic results are not immediately available and follow-up is uncertain 1

Sexual Activity Resumption

Patients should abstain from all sexual contact (including oral sex) until:

  • Treatment is complete AND
  • All visible lesions have completely healed AND
  • Sex partners have been evaluated and treated 4

Pregnancy Screening

  • All pregnant women should be screened for syphilis at first prenatal visit, during third trimester, and at delivery 2, 1
  • Any woman who delivers a stillborn infant after 20 weeks gestation should be tested for syphilis 2
  • No infant should leave the hospital without the mother's serologic status having been determined at least once during pregnancy 2

Common Pitfalls to Avoid

  • Never use oral penicillin preparations for syphilis treatment—they are ineffective 1
  • Do not use azithromycin in the United States due to widespread resistance 1
  • Do not substitute alternatives for penicillin in pregnancy or neurosyphilis—desensitization is mandatory 2, 1, 3
  • Procaine penicillin without probenecid does not achieve adequate CSF levels and is inadequate for neurosyphilis 1
  • Do not switch between RPR and VDRL when monitoring serologic response—results cannot be directly compared 1, 3
  • Warn all patients about Jarisch-Herxheimer reaction—an acute febrile reaction with headache and myalgia that may occur within 24 hours of treatment, especially in early syphilis 1, 3

References

Guideline

Syphilis Treatment Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Syphilis Diagnosis and Treatment

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Treatment Efficacy and Sexual Activity Resumption After Penicillin G for Early Syphilis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.